Dactinomycin Intravenous and Myelosuppression
Result of checking the interaction of drug Dactinomycin Intravenous and disease Myelosuppression for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Severe and fatal myelosuppression, which may include neutropenia, thrombocytopenia and anemia, can occur with dactinomycin. If either the white blood cell or platelet count is markedly decreased, therapy with dactinomycin should be withheld or dose should be reduced to allow recovery. Therapy with dactinomycin should be administered cautiously in patients with myelosuppression. Close clinical monitoring of hematopoietic function is recommended.
- "Product Information. Cosmegen (dactinomycin)." Merck & Co, Inc, West Point, PA.
Generic Name: dactinomycin
Brand Name: Cosmegen
Synonyms: Dactinomycin, DACTINomycin